Venous Thromboembolism Therapy with Apixaban in Daily Care Patients: Results from the Dresden NOAC Registry

Venous Thromboembolism Therapy with Apixaban in Daily Care Patients: Results from the Dresden NOAC Registry

The effectiveness and safety of venous thromboembolism (VTE) treatment with apixaban, demonstrated in phase III trials, need to be confirmed in daily care. Using data from the prospective, noninterventional cross-indication Dresden NOAC Registry we evaluated rates of VTE recurrence and bleeding comp...

Full description

Bibliographic Details
Main Authors: Jan Beyer-Westendorf, Sandra Marten, Luise Tittl, Christiane Naue, Martin Bornhäuser
Format: Article
Language:English
Published: Georg Thieme Verlag KG 2021-04-01
Series:TH Open
Subjects:
anticoagulation
bleeding
persistence
apixaban
venous thromboembolism
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0041-1728675

Internet

http://www.thieme-connect.de/DOI/DOI?10.1055/s-0041-1728675

Similar Items